1 | orally | 4,880 |
2 | intravenously | 2,264 |
3 | subcutaneously | 882 |
4 | intramuscularly | 569 |
5 | topically | 457 |
6 | intraperitoneally | 442 |
7 | vaginally | 415 |
8 | prophylactically | 244 |
9 | parenterally | 231 |
10 | intranasally | 183 |
11 | percutaneously | 122 |
12 | intrathecally | 104 |
13 | intragastrically | 94 |
14 | sublingually | 92 |
15 | rectally | 90 |
16 | intravaginally | 68 |
17 | enterally | 65 |
18 | epidurally | 65 |
19 | intradermally | 64 |
20 | nasally | 45 |
21 | cyclically | 44 |
22 | adjunctively | 34 |
23 | transdermally | 31 |
24 | intravesically | 27 |
25 | intra-articularly | 26 |
26 | perorally | 26 |
27 | intratracheally | 25 |
28 | transversely | 21 |
29 | transurethrally | 20 |
30 | intraarticularly | 16 |
31 | intra-arterially | 15 |
32 | intracerebroventricularly | 15 |
33 | intravitreally | 15 |
34 | spinally | 14 |
35 | subgingivally | 11 |
36 | transcervically | 10 |
37 | decocted | 9 |
38 | non-occlusally | 9 |
39 | subconjunctivally | 9 |
40 | submucosally | 9 |
41 | discontinuously | 8 |
42 | ibond | 8 |
43 | mesiodistally | 8 |
44 | perineurally | 8 |
45 | pre-emptively | 8 |
46 | twice/week | 8 |
47 | ²²³ra | 8 |
48 | intraarterially | 7 |
49 | intratumorally | 7 |
50 | subdermally | 7 |
51 | intra-gastrically | 6 |
52 | intracervically | 6 |
53 | intracoronarily | 6 |
54 | intraventricularly | 6 |
55 | buccolingually | 5 |
56 | intra-peritoneally | 5 |
57 | intra-tracheally | 5 |
58 | intracranially | 5 |
59 | intraduodenally | 5 |
60 | intragastricly | 5 |
61 | intramyocardially | 5 |
62 | intraportally | 5 |
63 | intrarectally | 5 |
64 | intraruminally | 5 |
65 | intratympanically | 5 |
66 | lullabies | 5 |
67 | postcoitally | 5 |
68 | preseasonally | 5 |
69 | subchronically | 5 |
70 | transvenously | 5 |
71 | xylazine/ketamine | 5 |
72 | ecosprin | 4 |
73 | endocardially | 4 |
74 | endovenously | 4 |
75 | extradurally | 4 |
76 | intracerebrally | 4 |
77 | intracutaneously | 4 |
78 | intralesionally | 4 |
79 | iohexol-350 | 4 |
80 | mifepriston | 4 |
81 | neoadjuvantly | 4 |
82 | nocturnally | 4 |
83 | non-peeled | 4 |
84 | precoitally | 4 |
85 | predilections | 4 |
86 | subacromially | 4 |
87 | subendocardially | 4 |
88 | transendocardially | 4 |
89 | xfdcp | 4 |
90 | 3-triol | 3 |
91 | 400μg | 3 |
92 | 40iu | 3 |
93 | 4μg/kg | 3 |
94 | 5-days-a-week | 3 |
95 | adp21-50 | 3 |
96 | bcecf-am | 3 |
97 | bronuck | 3 |
98 | dermally | 3 |
99 | dose/g | 3 |
100 | efla943 | 3 |
101 | en101 | 3 |
102 | enhancer-wl | 3 |
103 | i.m.. | 3 |
104 | intra-nasally | 3 |
105 | intra-rectally | 3 |
106 | intracavernously | 3 |
107 | intraperitonally | 3 |
108 | intraperitonially | 3 |
109 | intraumbilically | 3 |
110 | intravascularly | 3 |
111 | odps | 3 |
112 | periarticularly | 3 |
113 | periurethrally | 3 |
114 | permaquick | 3 |
115 | persicatm | 3 |
116 | prepurified | 3 |
117 | rasis | 3 |
118 | s.c.. | 3 |
119 | stereotaxically | 3 |
120 | teat-sealant | 3 |
121 | transversally | 3 |
122 | tribromoethanol | 3 |
123 | vcp205 | 3 |
124 | .chm | 2 |
125 | 20/01/03 | 2 |
126 | 30/10/2002 | 2 |
127 | 3ap4 | 2 |
128 | 5000iu | 2 |
129 | 6mgkg-¹ | 2 |
130 | 732.2 | 2 |
131 | albumin-ifnα2b | 2 |
132 | alpha-phenyl | 2 |
133 | bucco-lingually | 2 |
134 | distolingually | 2 |
135 | extraamniotically | 2 |
136 | ftivazid | 2 |
137 | goshuyu-to | 2 |
138 | hallucinating | 2 |
139 | hylak | 2 |
140 | i.c.v. | 2 |
141 | intra-camerally | 2 |
142 | intra-muscularly | 2 |
143 | intraductally | 2 |
144 | intramammarily | 2 |
145 | intrasplenically | 2 |
146 | intrastriatally | 2 |
147 | lactinex | 2 |
148 | mcc-crm197 | 2 |
149 | mesio-distally | 2 |
150 | met-gh | 2 |
151 | metronomically | 2 |
152 | muons | 2 |
153 | noncontingently | 2 |
154 | nonstatins | 2 |
155 | oromucosally | 2 |
156 | p-sro | 2 |
157 | peri-incisionally | 2 |
158 | perianally | 2 |
159 | periareolarly | 2 |
160 | periprostatically | 2 |
161 | poskm | 2 |
162 | post-consent | 2 |
163 | postplacentally | 2 |
164 | provase | 2 |
165 | r-568 | 2 |
166 | rs/d | 2 |
167 | self-incentives | 2 |
168 | shallowly | 2 |
169 | sokei-kakketsu-to | 2 |
170 | standard-potency | 2 |
171 | transbucally | 2 |
172 | transtracheally | 2 |
173 | ultracortene-h | 2 |
174 | ‘tianwang | 2 |
175 | 0.3-10μg | 1 |
176 | 01/06/09 | 1 |
177 | 1,800-mg/day | 1 |
178 | 1-norm | 1 |
179 | 1.74g/kg | 1 |
180 | 10mls | 1 |
181 | 15.11.01 | 1 |
182 | 400/100mg | 1 |
183 | 533/133mg | 1 |
184 | 8.75mg | 1 |
185 | 80/40/80 | 1 |
186 | =1mg | 1 |
187 | =2mg | 1 |
188 | adenosine2a | 1 |
189 | ambiphrya | 1 |
190 | anodynes | 1 |
191 | anticholinergic-oxybutynin | 1 |
192 | before/after/during | 1 |
193 | birth.there | 1 |
194 | bivs | 1 |
195 | c592g | 1 |
196 | carbamate-irs | 1 |
197 | cauteously | 1 |
198 | ceftriaxone/ornidazole | 1 |
199 | celiacly | 1 |
200 | cell-puramatrix™ | 1 |
201 | cementfree | 1 |
202 | chromium-nicotinate | 1 |
203 | clinic-initiated | 1 |
204 | continuouly | 1 |
205 | control-feed | 1 |
206 | curcunine | 1 |
207 | dacthal | 1 |
208 | daily-1 | 1 |
209 | dhea-enanthate | 1 |
210 | diol/g | 1 |
211 | donor-organs | 1 |
212 | dosages.when | 1 |
213 | dply/phtd | 1 |
214 | du-6859a | 1 |
215 | e2:0.13mg/kg/d | 1 |
216 | eighty-item | 1 |
217 | emgfp | 1 |
218 | epicrestally | 1 |
219 | every-3-months | 1 |
220 | femur-were | 1 |
221 | fluouroracil | 1 |
222 | fst-ll | 1 |
223 | g-gr/d | 1 |
224 | gastrically | 1 |
225 | hcd-enriched | 1 |
226 | health-visitor | 1 |
227 | hmm+iptc | 1 |
228 | hydroxyprednisone | 1 |
229 | i.pl. | 1 |
230 | immaturely | 1 |
231 | industrywide | 1 |
232 | inhalatively | 1 |
233 | inteviewer | 1 |
234 | intra-amniotically | 1 |
235 | intra-crop | 1 |
236 | intra-gluteally | 1 |
237 | intra-tumourally | 1 |
238 | intra-umbilically | 1 |
239 | intra-urethrically | 1 |
240 | intraartricular | 1 |
241 | intrabronchially | 1 |
242 | intradermallly | 1 |
243 | intrafascicularly | 1 |
244 | intrahippocampally | 1 |
245 | intramenstrually | 1 |
246 | intraperitonelly | 1 |
247 | intrapulmonarily | 1 |
248 | intraputamenally | 1 |
249 | intrastromally | 1 |
250 | intratendinously | 1 |
251 | intratumourally | 1 |
252 | intravasally | 1 |
253 | intravitreously | 1 |
254 | lauriad® | 1 |
255 | leuprolide/bicalutamide | 1 |
256 | levothyroxine/day | 1 |
257 | lidocanine | 1 |
258 | living-training | 1 |
259 | manually/bodily | 1 |
260 | mate-outcome | 1 |
261 | methenaminehippurate | 1 |
262 | methyprednisolone | 1 |
263 | midazolam/placebo | 1 |
264 | moxaverine-hydrochloride | 1 |
265 | nasoenterically | 1 |
266 | neuraxially | 1 |
267 | nijututo | 1 |
268 | okt3-based | 1 |
269 | once-/twice-/thrice-daily | 1 |
270 | oxytotics | 1 |
271 | parentyerally | 1 |
272 | pavulon | 1 |
273 | per-orally | 1 |
274 | perianal-intrarectally | 1 |
275 | pericapsularly | 1 |
276 | peridurally | 1 |
277 | perivenously | 1 |
278 | peroraly | 1 |
279 | post-orally | 1 |
280 | post-symptomatically | 1 |
281 | power3-cifn-α | 1 |
282 | presymptomatically | 1 |
283 | qids-cr | 1 |
284 | quasi-statically | 1 |
285 | rechemotherapy | 1 |
286 | remifentanil/hour | 1 |
287 | results.pegloticase | 1 |
288 | rf-tricom | 1 |
289 | s.c./week | 1 |
290 | saha/kg | 1 |
291 | seisinrensiin | 1 |
292 | single-crowns | 1 |
293 | single/repeated | 1 |
294 | stepwisely | 1 |
295 | sub-group-matched | 1 |
296 | subcutaneosly | 1 |
297 | sulfadiazine-trimethroprim | 1 |
298 | sulfanegen | 1 |
299 | suprachoroidally | 1 |
300 | taniia:60mg/kg/d | 1 |
301 | teat-sealants | 1 |
302 | teeth/s | 1 |
303 | transorbitally | 1 |
304 | trimetoprim-sulphametoxazole | 1 |
305 | twice-once | 1 |
306 | were/was | 1 |
307 | wormer | 1 |
308 | xylasine | 1 |
309 | xylazine-guaifenesin | 1 |
310 | zeolite/cow | 1 |
311 | δvolume | 1 |
312 | μ-hole | 1 |
1 | .chm | 2 |
2 | 0.3-10μg | 1 |
3 | 01/06/09 | 1 |
4 | 1,800-mg/day | 1 |
5 | 1-norm | 1 |
6 | 1.74g/kg | 1 |
7 | 10mls | 1 |
8 | 15.11.01 | 1 |
9 | 20/01/03 | 2 |
10 | 3-triol | 3 |
11 | 30/10/2002 | 2 |
12 | 3ap4 | 2 |
13 | 400/100mg | 1 |
14 | 400μg | 3 |
15 | 40iu | 3 |
16 | 4μg/kg | 3 |
17 | 5-days-a-week | 3 |
18 | 5000iu | 2 |
19 | 533/133mg | 1 |
20 | 6mgkg-¹ | 2 |
21 | 732.2 | 2 |
22 | 8.75mg | 1 |
23 | 80/40/80 | 1 |
24 | =1mg | 1 |
25 | =2mg | 1 |
26 | adenosine2a | 1 |
27 | adjunctively | 34 |
28 | adp21-50 | 3 |
29 | albumin-ifnα2b | 2 |
30 | alpha-phenyl | 2 |
31 | ambiphrya | 1 |
32 | anodynes | 1 |
33 | anticholinergic-oxybutynin | 1 |
34 | bcecf-am | 3 |
35 | before/after/during | 1 |
36 | birth.there | 1 |
37 | bivs | 1 |
38 | bronuck | 3 |
39 | bucco-lingually | 2 |
40 | buccolingually | 5 |
41 | c592g | 1 |
42 | carbamate-irs | 1 |
43 | cauteously | 1 |
44 | ceftriaxone/ornidazole | 1 |
45 | celiacly | 1 |
46 | cell-puramatrix™ | 1 |
47 | cementfree | 1 |
48 | chromium-nicotinate | 1 |
49 | clinic-initiated | 1 |
50 | continuouly | 1 |
51 | control-feed | 1 |
52 | curcunine | 1 |
53 | cyclically | 44 |
54 | dacthal | 1 |
55 | daily-1 | 1 |
56 | decocted | 9 |
57 | dermally | 3 |
58 | dhea-enanthate | 1 |
59 | diol/g | 1 |
60 | discontinuously | 8 |
61 | distolingually | 2 |
62 | donor-organs | 1 |
63 | dosages.when | 1 |
64 | dose/g | 3 |
65 | dply/phtd | 1 |
66 | du-6859a | 1 |
67 | e2:0.13mg/kg/d | 1 |
68 | ecosprin | 4 |
69 | efla943 | 3 |
70 | eighty-item | 1 |
71 | emgfp | 1 |
72 | en101 | 3 |
73 | endocardially | 4 |
74 | endovenously | 4 |
75 | enhancer-wl | 3 |
76 | enterally | 65 |
77 | epicrestally | 1 |
78 | epidurally | 65 |
79 | every-3-months | 1 |
80 | extraamniotically | 2 |
81 | extradurally | 4 |
82 | femur-were | 1 |
83 | fluouroracil | 1 |
84 | fst-ll | 1 |
85 | ftivazid | 2 |
86 | g-gr/d | 1 |
87 | gastrically | 1 |
88 | goshuyu-to | 2 |
89 | hallucinating | 2 |
90 | hcd-enriched | 1 |
91 | health-visitor | 1 |
92 | hmm+iptc | 1 |
93 | hydroxyprednisone | 1 |
94 | hylak | 2 |
95 | i.c.v. | 2 |
96 | i.m.. | 3 |
97 | i.pl. | 1 |
98 | ibond | 8 |
99 | immaturely | 1 |
100 | industrywide | 1 |
101 | inhalatively | 1 |
102 | inteviewer | 1 |
103 | intra-amniotically | 1 |
104 | intra-arterially | 15 |
105 | intra-articularly | 26 |
106 | intra-camerally | 2 |
107 | intra-crop | 1 |
108 | intra-gastrically | 6 |
109 | intra-gluteally | 1 |
110 | intra-muscularly | 2 |
111 | intra-nasally | 3 |
112 | intra-peritoneally | 5 |
113 | intra-rectally | 3 |
114 | intra-tracheally | 5 |
115 | intra-tumourally | 1 |
116 | intra-umbilically | 1 |
117 | intra-urethrically | 1 |
118 | intraarterially | 7 |
119 | intraarticularly | 16 |
120 | intraartricular | 1 |
121 | intrabronchially | 1 |
122 | intracavernously | 3 |
123 | intracerebrally | 4 |
124 | intracerebroventricularly | 15 |
125 | intracervically | 6 |
126 | intracoronarily | 6 |
127 | intracranially | 5 |
128 | intracutaneously | 4 |
129 | intradermallly | 1 |
130 | intradermally | 64 |
131 | intraductally | 2 |
132 | intraduodenally | 5 |
133 | intrafascicularly | 1 |
134 | intragastrically | 94 |
135 | intragastricly | 5 |
136 | intrahippocampally | 1 |
137 | intralesionally | 4 |
138 | intramammarily | 2 |
139 | intramenstrually | 1 |
140 | intramuscularly | 569 |
141 | intramyocardially | 5 |
142 | intranasally | 183 |
143 | intraperitonally | 3 |
144 | intraperitoneally | 442 |
145 | intraperitonelly | 1 |
146 | intraperitonially | 3 |
147 | intraportally | 5 |
148 | intrapulmonarily | 1 |
149 | intraputamenally | 1 |
150 | intrarectally | 5 |
151 | intraruminally | 5 |
152 | intrasplenically | 2 |
153 | intrastriatally | 2 |
154 | intrastromally | 1 |
155 | intratendinously | 1 |
156 | intrathecally | 104 |
157 | intratracheally | 25 |
158 | intratumorally | 7 |
159 | intratumourally | 1 |
160 | intratympanically | 5 |
161 | intraumbilically | 3 |
162 | intravaginally | 68 |
163 | intravasally | 1 |
164 | intravascularly | 3 |
165 | intravenously | 2,264 |
166 | intraventricularly | 6 |
167 | intravesically | 27 |
168 | intravitreally | 15 |
169 | intravitreously | 1 |
170 | iohexol-350 | 4 |
171 | lactinex | 2 |
172 | lauriad® | 1 |
173 | leuprolide/bicalutamide | 1 |
174 | levothyroxine/day | 1 |
175 | lidocanine | 1 |
176 | living-training | 1 |
177 | lullabies | 5 |
178 | manually/bodily | 1 |
179 | mate-outcome | 1 |
180 | mcc-crm197 | 2 |
181 | mesio-distally | 2 |
182 | mesiodistally | 8 |
183 | met-gh | 2 |
184 | methenaminehippurate | 1 |
185 | methyprednisolone | 1 |
186 | metronomically | 2 |
187 | midazolam/placebo | 1 |
188 | mifepriston | 4 |
189 | moxaverine-hydrochloride | 1 |
190 | muons | 2 |
191 | nasally | 45 |
192 | nasoenterically | 1 |
193 | neoadjuvantly | 4 |
194 | neuraxially | 1 |
195 | nijututo | 1 |
196 | nocturnally | 4 |
197 | non-occlusally | 9 |
198 | non-peeled | 4 |
199 | noncontingently | 2 |
200 | nonstatins | 2 |
201 | odps | 3 |
202 | okt3-based | 1 |
203 | once-/twice-/thrice-daily | 1 |
204 | orally | 4,880 |
205 | oromucosally | 2 |
206 | oxytotics | 1 |
207 | p-sro | 2 |
208 | parenterally | 231 |
209 | parentyerally | 1 |
210 | pavulon | 1 |
211 | per-orally | 1 |
212 | percutaneously | 122 |
213 | peri-incisionally | 2 |
214 | perianal-intrarectally | 1 |
215 | perianally | 2 |
216 | periareolarly | 2 |
217 | periarticularly | 3 |
218 | pericapsularly | 1 |
219 | peridurally | 1 |
220 | perineurally | 8 |
221 | periprostatically | 2 |
222 | periurethrally | 3 |
223 | perivenously | 1 |
224 | permaquick | 3 |
225 | perorally | 26 |
226 | peroraly | 1 |
227 | persicatm | 3 |
228 | poskm | 2 |
229 | post-consent | 2 |
230 | post-orally | 1 |
231 | post-symptomatically | 1 |
232 | postcoitally | 5 |
233 | postplacentally | 2 |
234 | power3-cifn-α | 1 |
235 | pre-emptively | 8 |
236 | precoitally | 4 |
237 | predilections | 4 |
238 | prepurified | 3 |
239 | preseasonally | 5 |
240 | presymptomatically | 1 |
241 | prophylactically | 244 |
242 | provase | 2 |
243 | qids-cr | 1 |
244 | quasi-statically | 1 |
245 | r-568 | 2 |
246 | rasis | 3 |
247 | rechemotherapy | 1 |
248 | rectally | 90 |
249 | remifentanil/hour | 1 |
250 | results.pegloticase | 1 |
251 | rf-tricom | 1 |
252 | rs/d | 2 |
253 | s.c.. | 3 |
254 | s.c./week | 1 |
255 | saha/kg | 1 |
256 | seisinrensiin | 1 |
257 | self-incentives | 2 |
258 | shallowly | 2 |
259 | single-crowns | 1 |
260 | single/repeated | 1 |
261 | sokei-kakketsu-to | 2 |
262 | spinally | 14 |
263 | standard-potency | 2 |
264 | stepwisely | 1 |
265 | stereotaxically | 3 |
266 | sub-group-matched | 1 |
267 | subacromially | 4 |
268 | subchronically | 5 |
269 | subconjunctivally | 9 |
270 | subcutaneosly | 1 |
271 | subcutaneously | 882 |
272 | subdermally | 7 |
273 | subendocardially | 4 |
274 | subgingivally | 11 |
275 | sublingually | 92 |
276 | submucosally | 9 |
277 | sulfadiazine-trimethroprim | 1 |
278 | sulfanegen | 1 |
279 | suprachoroidally | 1 |
280 | taniia:60mg/kg/d | 1 |
281 | teat-sealant | 3 |
282 | teat-sealants | 1 |
283 | teeth/s | 1 |
284 | topically | 457 |
285 | transbucally | 2 |
286 | transcervically | 10 |
287 | transdermally | 31 |
288 | transendocardially | 4 |
289 | transorbitally | 1 |
290 | transtracheally | 2 |
291 | transurethrally | 20 |
292 | transvenously | 5 |
293 | transversally | 3 |
294 | transversely | 21 |
295 | tribromoethanol | 3 |
296 | trimetoprim-sulphametoxazole | 1 |
297 | twice-once | 1 |
298 | twice/week | 8 |
299 | ultracortene-h | 2 |
300 | vaginally | 415 |
301 | vcp205 | 3 |
302 | were/was | 1 |
303 | wormer | 1 |
304 | xfdcp | 4 |
305 | xylasine | 1 |
306 | xylazine-guaifenesin | 1 |
307 | xylazine/ketamine | 5 |
308 | zeolite/cow | 1 |
309 | ²²³ra | 8 |
310 | δvolume | 1 |
311 | μ-hole | 1 |
312 | ‘tianwang | 2 |
1 | s.c.. | 3 |
2 | i.m.. | 3 |
3 | i.pl. | 1 |
4 | i.c.v. | 2 |
5 | adp21-50 | 3 |
6 | iohexol-350 | 4 |
7 | 80/40/80 | 1 |
8 | daily-1 | 1 |
9 | 15.11.01 | 1 |
10 | en101 | 3 |
11 | 732.2 | 2 |
12 | 30/10/2002 | 2 |
13 | 20/01/03 | 2 |
14 | efla943 | 3 |
15 | 3ap4 | 2 |
16 | vcp205 | 3 |
17 | mcc-crm197 | 2 |
18 | r-568 | 2 |
19 | 01/06/09 | 1 |
20 | adenosine2a | 1 |
21 | du-6859a | 1 |
22 | ²²³ra | 8 |
23 | ambiphrya | 1 |
24 | albumin-ifnα2b | 2 |
25 | hmm+iptc | 1 |
26 | taniia:60mg/kg/d | 1 |
27 | e2:0.13mg/kg/d | 1 |
28 | g-gr/d | 1 |
29 | rs/d | 2 |
30 | control-feed | 1 |
31 | hcd-enriched | 1 |
32 | sub-group-matched | 1 |
33 | prepurified | 3 |
34 | non-peeled | 4 |
35 | okt3-based | 1 |
36 | single/repeated | 1 |
37 | clinic-initiated | 1 |
38 | decocted | 9 |
39 | ftivazid | 2 |
40 | ibond | 8 |
41 | dply/phtd | 1 |
42 | twice-once | 1 |
43 | leuprolide/bicalutamide | 1 |
44 | moxaverine-hydrochloride | 1 |
45 | industrywide | 1 |
46 | cementfree | 1 |
47 | μ-hole | 1 |
48 | ceftriaxone/ornidazole | 1 |
49 | trimetoprim-sulphametoxazole | 1 |
50 | mate-outcome | 1 |
51 | δvolume | 1 |
52 | xylazine/ketamine | 5 |
53 | lidocanine | 1 |
54 | curcunine | 1 |
55 | xylasine | 1 |
56 | methyprednisolone | 1 |
57 | hydroxyprednisone | 1 |
58 | birth.there | 1 |
59 | femur-were | 1 |
60 | results.pegloticase | 1 |
61 | provase | 2 |
62 | dhea-enanthate | 1 |
63 | chromium-nicotinate | 1 |
64 | methenaminehippurate | 1 |
65 | dose/g | 3 |
66 | diol/g | 1 |
67 | c592g | 1 |
68 | saha/kg | 1 |
69 | 1.74g/kg | 1 |
70 | 4μg/kg | 3 |
71 | 400/100mg | 1 |
72 | =1mg | 1 |
73 | =2mg | 1 |
74 | 533/133mg | 1 |
75 | 8.75mg | 1 |
76 | ‘tianwang | 2 |
77 | living-training | 1 |
78 | before/after/during | 1 |
79 | hallucinating | 2 |
80 | 400μg | 3 |
81 | 0.3-10μg | 1 |
82 | ultracortene-h | 2 |
83 | met-gh | 2 |
84 | hylak | 2 |
85 | permaquick | 3 |
86 | bronuck | 3 |
87 | 5-days-a-week | 3 |
88 | s.c./week | 1 |
89 | twice/week | 8 |
90 | dacthal | 1 |
91 | fluouroracil | 1 |
92 | fst-ll | 1 |
93 | 3-triol | 3 |
94 | tribromoethanol | 3 |
95 | enhancer-wl | 3 |
96 | alpha-phenyl | 2 |
97 | bcecf-am | 3 |
98 | eighty-item | 1 |
99 | .chm | 2 |
100 | sulfadiazine-trimethroprim | 1 |
101 | poskm | 2 |
102 | rf-tricom | 1 |
103 | 1-norm | 1 |
104 | persicatm | 3 |
105 | sulfanegen | 1 |
106 | dosages.when | 1 |
107 | seisinrensiin | 1 |
108 | anticholinergic-oxybutynin | 1 |
109 | ecosprin | 4 |
110 | xylazine-guaifenesin | 1 |
111 | pavulon | 1 |
112 | mifepriston | 4 |
113 | midazolam/placebo | 1 |
114 | p-sro | 2 |
115 | sokei-kakketsu-to | 2 |
116 | goshuyu-to | 2 |
117 | nijututo | 1 |
118 | xfdcp | 4 |
119 | emgfp | 1 |
120 | intra-crop | 1 |
121 | intraartricular | 1 |
122 | qids-cr | 1 |
123 | wormer | 1 |
124 | inteviewer | 1 |
125 | health-visitor | 1 |
126 | remifentanil/hour | 1 |
127 | teeth/s | 1 |
128 | were/was | 1 |
129 | oxytotics | 1 |
130 | lullabies | 5 |
131 | anodynes | 1 |
132 | self-incentives | 2 |
133 | every-3-months | 1 |
134 | rasis | 3 |
135 | 10mls | 1 |
136 | donor-organs | 1 |
137 | nonstatins | 2 |
138 | predilections | 4 |
139 | muons | 2 |
140 | single-crowns | 1 |
141 | odps | 3 |
142 | carbamate-irs | 1 |
143 | teat-sealants | 1 |
144 | bivs | 1 |
145 | teat-sealant | 3 |
146 | post-consent | 2 |
147 | 5000iu | 2 |
148 | 40iu | 3 |
149 | zeolite/cow | 1 |
150 | lactinex | 2 |
151 | levothyroxine/day | 1 |
152 | 1,800-mg/day | 1 |
153 | standard-potency | 2 |
154 | peroraly | 1 |
155 | celiacly | 1 |
156 | intragastricly | 5 |
157 | immaturely | 1 |
158 | stepwisely | 1 |
159 | transversely | 21 |
160 | inhalatively | 1 |
161 | adjunctively | 34 |
162 | pre-emptively | 8 |
163 | once-/twice-/thrice-daily | 1 |
164 | manually/bodily | 1 |
165 | intramammarily | 2 |
166 | intrapulmonarily | 1 |
167 | intracoronarily | 6 |
168 | intrathecally | 104 |
169 | cyclically | 44 |
170 | intra-umbilically | 1 |
171 | intraumbilically | 3 |
172 | metronomically | 2 |
173 | intratympanically | 5 |
174 | intrasplenically | 2 |
175 | subchronically | 5 |
176 | topically | 457 |
177 | nasoenterically | 1 |
178 | intra-urethrically | 1 |
179 | gastrically | 1 |
180 | intra-gastrically | 6 |
181 | intragastrically | 94 |
182 | intravesically | 27 |
183 | post-symptomatically | 1 |
184 | presymptomatically | 1 |
185 | quasi-statically | 1 |
186 | periprostatically | 2 |
187 | prophylactically | 244 |
188 | intra-amniotically | 1 |
189 | extraamniotically | 2 |
190 | intracervically | 6 |
191 | transcervically | 10 |
192 | stereotaxically | 3 |
193 | transbucally | 2 |
194 | suprachoroidally | 1 |
195 | intra-tracheally | 5 |
196 | intratracheally | 25 |
197 | transtracheally | 2 |
198 | intra-peritoneally | 5 |
199 | intraperitoneally | 442 |
200 | intravitreally | 15 |
201 | intra-gluteally | 1 |
202 | endocardially | 4 |
203 | subendocardially | 4 |
204 | transendocardially | 4 |
205 | intramyocardially | 5 |
206 | intrabronchially | 1 |
207 | subacromially | 4 |
208 | intracranially | 5 |
209 | intraperitonially | 3 |
210 | intra-arterially | 15 |
211 | intraarterially | 7 |
212 | neuraxially | 1 |
213 | intrastromally | 1 |
214 | dermally | 3 |
215 | intradermally | 64 |
216 | subdermally | 7 |
217 | transdermally | 31 |
218 | perianally | 2 |
219 | intraduodenally | 5 |
220 | intraputamenally | 1 |
221 | vaginally | 415 |
222 | intravaginally | 68 |
223 | intraruminally | 5 |
224 | spinally | 14 |
225 | intralesionally | 4 |
226 | peri-incisionally | 2 |
227 | preseasonally | 5 |
228 | intraperitonally | 3 |
229 | nocturnally | 4 |
230 | intrahippocampally | 1 |
231 | intracerebrally | 4 |
232 | intra-camerally | 2 |
233 | enterally | 65 |
234 | parenterally | 231 |
235 | parentyerally | 1 |
236 | periurethrally | 3 |
237 | transurethrally | 20 |
238 | orally | 4,880 |
239 | per-orally | 1 |
240 | post-orally | 1 |
241 | intratumorally | 7 |
242 | perorally | 26 |
243 | extradurally | 4 |
244 | epidurally | 65 |
245 | peridurally | 1 |
246 | perineurally | 8 |
247 | intra-tumourally | 1 |
248 | intratumourally | 1 |
249 | nasally | 45 |
250 | intra-nasally | 3 |
251 | intranasally | 183 |
252 | intravasally | 1 |
253 | submucosally | 9 |
254 | oromucosally | 2 |
255 | transversally | 3 |
256 | non-occlusally | 9 |
257 | intrastriatally | 2 |
258 | rectally | 90 |
259 | intra-rectally | 3 |
260 | intrarectally | 5 |
261 | perianal-intrarectally | 1 |
262 | intraductally | 2 |
263 | transorbitally | 1 |
264 | precoitally | 4 |
265 | postcoitally | 5 |
266 | postplacentally | 2 |
267 | intraportally | 5 |
268 | epicrestally | 1 |
269 | mesio-distally | 2 |
270 | mesiodistally | 8 |
271 | bucco-lingually | 2 |
272 | sublingually | 92 |
273 | buccolingually | 5 |
274 | distolingually | 2 |
275 | intramenstrually | 1 |
276 | subgingivally | 11 |
277 | subconjunctivally | 9 |
278 | intraperitonelly | 1 |
279 | intradermallly | 1 |
280 | periareolarly | 2 |
281 | intrafascicularly | 1 |
282 | intraventricularly | 6 |
283 | intracerebroventricularly | 15 |
284 | intra-articularly | 26 |
285 | intraarticularly | 16 |
286 | periarticularly | 3 |
287 | intravascularly | 3 |
288 | intra-muscularly | 2 |
289 | intramuscularly | 569 |
290 | pericapsularly | 1 |
291 | subcutaneosly | 1 |
292 | intracutaneously | 4 |
293 | subcutaneously | 882 |
294 | percutaneously | 122 |
295 | intravitreously | 1 |
296 | cauteously | 1 |
297 | intravenously | 2,264 |
298 | perivenously | 1 |
299 | endovenously | 4 |
300 | transvenously | 5 |
301 | intratendinously | 1 |
302 | intracavernously | 3 |
303 | discontinuously | 8 |
304 | neoadjuvantly | 4 |
305 | noncontingently | 2 |
306 | continuouly | 1 |
307 | shallowly | 2 |
308 | rechemotherapy | 1 |
309 | cell-puramatrix™ | 1 |
310 | lauriad® | 1 |
311 | power3-cifn-α | 1 |
312 | 6mgkg-¹ | 2 |